Spyre Therapeutics Inc (SYRE)

Equity Ratio

93.87%

Quarterly · Period ending:

SYRE logo

SYRE Equity Ratio

Latest reported93.87%
SYRE Quarterly Equity Ratio (63.89% → 93.87%)
High-resolution chart · PNG

SYRE equity ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Equity Ratio — Quarterly
Period endingEquity Ratio
93.8737%
87.8079%
91.9585%
90.1895%
84.5854%
84.7014%
85.0974%
77.7484%
85.8549%
31.2281%
53.828%
-118.4001%
-85.1517%
64.1565%
70.7087%
73.7774%
78.8674%
74.1337%
76.3614%
79.0952%
80.9786%
75.6384%
86.5201%
87.5622%
88.0557%
66.0765%
72.2275%
79.7185%
84.7831%
90.4839%
86.7364%
89.343%
92.1393%
88.2176%
89.7641%
91.7457%
93.2384%
93.3341%
93.8908%
94.6393%
95.6314%
89.1906%
93.403%
94.1786%
94.0011%
97.2266%
63.8908%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.